FindTrial
Sign In

Correlation between Anti CCP autoantibody concentration and severity of Rheumatoid arthritis (Sandhiva)

Correlation between Anti Cyclic citrulinated peptide (Anti-CCP)antibody titre and disease severity in Rheumatoid Arthritis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060765
Enrollment
43
Registered
2023-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Sponsors

All India Institute of Medical Sciences Rajkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients above 18 years of age Patients having Rheumatoid Arthritis according to ACR EULAR 2010 crteria

Exclusion criteria

Exclusion criteria: Patient less than 18 years Pregnant and lactating female Those not giving valid consent

Design outcomes

Primary

MeasureTime frame
To correlate the titre anf anti CCP antibodies with the disease severity in patients with Rheumatoid arthritisTimepoint: 1 year 9 month data collection 3 months data analysis—

Secondary

MeasureTime frame
Which test is better associated with severity, Rheumatoid factor or Anti CCP antibodies?Timepoint: 2 years—

Countries

India

Contacts

Public ContactDr Anil Chaudhary

All India Institute of Medical Sciences Rajkot

acdranil@gmail.com9016579950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026